Francisco Romo-Nava , MD,PhD

Dr. Romo-Nava's clinical and translational research currently explores the role of brain-body communication in the context of psychiatric disorders. He graduated as MD at the Universidad Autonoma de San Luis Potosi, Mexico. He then completed his residency training in Psychiatry and a fellow in affective disorders at the National Institute of Psychiatry and the Universidad Nacional Autonoma de Mexico. Dr. Romo-Nava then graduated with honors obtaining a PhD in Biomedical Sciences with a focus in neuroscience and hypothalamic integration mechanisms at the Institute for Biomedical Research at the Universidad Nacional Autonoma de Mexico. He then completed a postdoctoral fellowship at the Division of Bipolar Disorder Research in the Department of Psychiatry and Behavioral Neurosciences, University of Cincinnati.    

MD: Universidad Autonoma de San Luis Potosi Mexico, 2003 (Medicine)

Psychiatrist: National Institute of Psychiatry/ Universidad Nacional Autonoma de Mexico Mexico, 2008 (Psychiatry)

Fellow Affective Disorders: National Institute of Psychiatry/ Universidad Nacional Autonoma de Mexico Mexico, 2009 (Affective Disorders)

PhD: Institute For Biomedical Research, Universidad Nacional Autonoma de Mexico Mexico, 2015 (Biomedical Science, Neuroscience)

2009 -2015 Psychiatrist, Private Office Psychiatric Attention, Private Office, Mexico

2009 -2010 Psychiatrist, Staff Psychiatrist. Specialist "A" , at the Affective Disorders Clinic, National Institute of Psychiatry "Dr. Ramon de la Fuente"., Mexico

2010 -2014 Academic Associate , Academic Associate in Research at the Department of Psychiatry and Mental Health, School of Medicine, UNAM, Mexico

2010 -2015 Academic Section Chief, Academic Section Chief and Coordinator of Research activities at the Department of Psychiatry and Mental Health., School of Medicine, UNAM. , Mexico

2015 - Postdoctoral Fellow, Division of Bipolar Disorder Researchm Department of Psychiatry and Behavioral Neuroscience, College of Medicine, University of Cincinnati, Cincinnati, Ohio

2017 -To Present Associate Chief Research Officer/ Assistant Professor, Lindner Center of HOPE/ Department of Psychiatry and Behavioral Neuroscience UC-COM, Mason, Ohio

Grant: #26649 Investigators:Romo-Nava, Francisco 01-15-2018 -01-14-2020 Brain & Behavior Research Foundation Spinal Cord Stimulation for the Treatment of Major Depressive Disorder Role:PI $70,000.00 Awarded Level:Private Non-Profit

Grant: #K23MH120503 Investigators:Romo-Nava, Francisco 07-01-2020 -06-30-2024 National Institute of Mental Health The role of the circadian system in binge eating disorder Role:PI $200,564.00 Awarded Level:Federal

Grant: #R61MH133770 Investigators:Awosika, Oluwole; Basu, Ishita; Fleck, David; McElroy, Susan; Romo-Nava, Francisco; Welge, Jeffrey -02-28-2029 National Institute of Mental Health Modulating spinal interoceptive pathways to evaluate their role and therapeutic potential in MDD symptomatic domains Role:PI 0.00 Hold Level:Federal

Peer Reviewed Publications

Nunez, Nicolas; Singh, Balwinder; Romo-Nava, Francisco; Joseph, Boney; Veldic, Marin; Cuellar-Barboza, Alfredo; Cabello Arreola, Alejandra; Vande Voort, Jennifer L; Croarkin, Paul; Moore, Katherine M; Biernacka, Joanna; McElroy, Susan L; Frye, Mark A (2019. ) Efficacy and tolerability of adjunctive modafinil /armodafinil in bipolar depression: a meta-analysis of randomized controlled trials.Bipolar disorders, , More Information

Frye, Mark A; Coombes, Brandon J; McElroy, Susan L; Jones-Brando, Lori; Bond, David J; Veldic, Marin; Romo-Nava, Francisco; Bobo, William V; Singh, Balwinder; Colby, Colin; Skime, Michelle K; Biernacka, Joanna M; Yolken, Robert (2019. ) Association of Cytomegalovirus and Toxoplasma gondii Antibody Titers With Bipolar Disorder.JAMA psychiatry, , More Information

Romo-Nava, Francisco; Bobadilla-Espinosa, Rosa I; Tafoya, Silvia A; Guízar-Sánchez, Diana P; Gutiérrez, Joaquín R; Carriedo, Pilar; Heinze, Gerhard (2019. ) Major depressive disorder in Mexican medical students and associated factors: A focus on current and past abuse experiences.Journal of affective disorders, , 245 ,834-840 More Information

McElroy, Susan L; Guerdjikova, Anna I; Mori, Nicole; Romo-Nava, Francisco (2019. ) Progress in Developing Pharmacologic Agents to Treat Bulimia Nervosa.CNS drugs, , 33 (1 ) ,31-46 More Information

Romo-Nava, Francisco; Buijs, Frederik N; Valdés-Tovar, Marcela; Benítez-King, Gloria; Basualdo, MariCarmen; Perusquía, Mercedes; Heinze, Gerhard; Escobar, Carolina; Buijs, Ruud M (2017. ) Olanzapine-induced early cardiovascular effects are mediated by the biological clock and prevented by melatonin.Journal of pineal research, , 62 (4 ) , More Information

Romo-Nava F, Buijs FN, Valdés-Tovar M, Benítez-King G, Basualdo M, Perusquía M, Heinze G, Escobar C, Buijs RM. (2017. ) Olanzapine-Induced Early Cardiovascular Effects are Mediated by the Biological Clock and Prevented by Melatonin. .J Pineal Res, , 62 (4 ) ,

Frederik N Buijs, Luis León-Mercado, Mara Guzmán-Ruiz4, Natali N Guerrero- Vargas, Francisco Romo-Nava, Ruud M Buijs. (2016. ) The circadian system: A regulatory feedback network of periphery and brain .Physiology, ,

Romo-Nava F, Tafoya SA, Gutiérrez-Soriano J, Osorio Y, Carriedo P, Ocampo B, Bobadilla RI, Heinze G. (2016. ) The Association between Chronotype and Perceived Academic Stress to Depression in Medical Students. .Chronobiol Int. , , Aug (31 ) ,1 -10

Buijs, Frederik N; León-Mercado, Luis; Guzmán-Ruiz, Mara; Guerrero-Vargas, Natali N; Romo-Nava, Francisco; Buijs, Ruud M (2016. ) The Circadian System: A Regulatory Feedback Network of Periphery and Brain.Physiology (Bethesda, Md.), , 31 (3 ) ,170-81 More Information

Romo-Nava, Francisco; Tafoya, Silvia A; Gutiérrez-Soriano, Joaquín; Osorio, Yanik; Carriedo, Pilar; Ocampo, Bárbara; Bobadilla, Rosa I; Heinze, Gerhard (2016. ) The association between chronotype and perceived academic stress to depression in medical students.Chronobiology international, , 33 (10 ) ,1359-1368 More Information

LLOYD CE, SARTORIUS N, CIMINO LC, ALVAREZ A, DE BRAUDE MG, RABBANI G, AHMED HU, PAPELBAUM M, DE FREITAS SR, JI L, YU X, GAEBEL W, MÜSSIG K, CHATURVEDI SK, SRIKANTA SS, BURTI L, BULGARI V, MUSAU A, NDETEI D, HEINZE MARTIN G, ROMO NAVA F, TAJ R, KHAN A, KOKOSZKA A, PAPASZ-SIEMIENIUK A, STAROSTINA EG, BOBROV AE, LECIC-TOSEVSKI D, LALIC NM, UDOMRATN P, TANGWONGCHAI S, BAHENDEKA S, BASANGWA D, MANKOVSKY B. (2015. ) THE INTERPRET-DD STUDY OF DIABETES AND DEPRESSION: A PROTOCOL. .Diabetes Med, , 32 (7 ) ,925 -934

ADRIANA DÍAZ-ANZALDÚA, YOLANDA OCAMPO-MENDOZA, JOSÉ OCTAVIO HERNÁNDEZ-LAGUNAS, FEDERICO ALEJANDRO DÍAZ-MADRID, FRANCISCO ROMO-NAVA, FRANCISCO JUÁREZ-GARCÍA, HIRAM ORTEGA-ORTIZ, ALEJANDRO DÍAZ-ANZALDÚA, DORIS GUTIÉRREZ-MORA, CLAUDIA BECERRA-PALARS BERLANGA-CISNEROS. (2015. ) DIFFERENCES IN BODY MASS INDEX ACCORDING TO FAT MASS- AND OBESITY-ASSOCIATED (FTO) GENOTYPE IN MEXICAN PATIENTS WITH BIPOLAR DISORDER. Bipolar Disorders, , 6 ,662 -669

ROMO- NAVA F, ALVAREZ-ICAZA D, FRESÁN- ORELLANA A, SARACCO R, BECERRA- PALARS C, MORENO J, ONTIVEROS MP, BERLANGA C, HEINZE G, BUIJS RM. (2014. ) MELATONIN ATTENUATES ANTIPSYCHOTIC METABOLIC EFFECTS: A DOUBLE BLIND RANDOMIZED, PLACEBO CONTROLLED, PARALLEL GROUP CLINICAL TRIAL. .Bipolar Disorders, , 16 (4 ) ,410 -421

ROMO-NAVA F, FRESÁN-ORELLANA A., BARRAGÁN V., SARACCO-ÁLVAREZ R., BECERRA-PALARS C, OSORIO Y, PÉREZ E., HEINZE H., LARA D.R. (2014. ) THE AFFECTIVE AND EMOTIONAL COMPOSITE TEMPERAMENT SCALE (AFECTS): PSYCHOMETRIC PROPERTIES OF THE SPANISH VERSION IN A COMMUNITY SAMPLE FROM MEXICO CITY AND COMPARISON BETWEEN REMITTED PSYCHIATRIC PATIENTS. .Journal of Affective Disorders, , 172 ,251 -258

SOLÍS-CHAGOYÁN H, CALIXTO E, FIGUEROA A, MONTAÑO LM, BERLANGA C, RODRÍGUEZ-VERDUGO MS, ROMO F, JIMÉNEZ M, GURROLA CZ, RIQUELME A, BENÍTEZ-KING G (2013. ) MICROTUBULE ORGANIZATION AND L-TYPE VOLTAGE-ACTIVATED CALCIUM CURRENT IN OLFACTORY NEURONAL CELLS OBTAINED FROM PATIENTS WITH SCHIZOPHRENIA AND BIPOLAR DISORDER. SCHIZOPHR RES, , 143 (2-3 ) ,384 -389

ROMO-NAVA F, HOOGENBOOM WS, PELAVIN PE, ALVARADO JL, BOBROW LH, MACMASTER FP, KESHAVAN M, MCCARLEY RW, SHENTON ME. (2013. ) PITUITARY VOLUME IN SCHIZOPHRENIA SPECTRUM DISORDERS .SCHIZOPHR RES, , 146 (1-3 ) ,301 -307

ROMO- NAVA F, TAFOYA A, CORTES J, HEINZE G (2013. ) A COMPARATIVE STUDY ON DEPRESSION AND ASSOCIATED FACTORS IN FIRST AND FIFTH YEAR MEDICAL STUDENTS. Salud Mental, , 36 ,375 -379

BENÍTEZ-KING G, RIQUELME A, ORTÍZ-LÓPEZ L, BERLANGA C, RODRÍGUEZ-VERDUGO MS, ROMO F, CALIXTO E, SOLÍS-CHAGOYÁN H, JÍMENEZ M, MONTAÑO LM, RAMÍREZ-RODRÍGUEZ G, MORALES-MULIA S, DOMÍNGUEZ-ALONSO A. (2011. ) A NON-INVASIVE METHOD TO ISOLATE THE NEURONAL LINAGE FROM THE NASAL EPITHELIUM FROM SCHIZOPHRENIC AND BIPOLAR DISEASES. J NEUROSCI METHODS. J NEUROSCI METHODS. , , 201 (1 ) ,35 -45

L. PALACIOS, F. ROMO, R. PATIÑO, BARRAGÁN E., LEYVA F., DE LA PEÑA F (2008. ) DEFICIT DISORDER ATTENTION-DEFICIT/HYPERACTIVITY DISORDER AND PEDIATRIC BIPOLAR DISORDER, COMORBIDITY OR OVERLAP? A REVIEW. PART ONE. Salud Mental, , 31 ,19 -22

. L. PALACIOS, F. ROMO, R. PATIÑO, BARRAGÁN E., LEYVA F., DE LA PEÑA F (2008. ) ATTENTION-DEFICIT/HYPERACTIVITY DISORDER AND PEDIATRIC BIPOLAR DISORDER, COMORBIDITY OR OVERLAP? A REVIEW. PART TWO. Salud Mental, , 31 (2 ) ,87 -92

Romo-Nava, Francisco; Blom, Thomas J; Guerdjikova, Anna; Winham, Stacey J; Cuellar-Barboza, Alfredo B; Nunez, Nicolas A; Balwinder, Singh; Biernacka, Joanna M; Frye, Mark A; McElroy, Susan L (2020. ) Evening Chronotype, Disordered Eating Behavior, and Poor Dietary Habits in Bipolar Disorder.Acta psychiatrica Scandinavica, , More Information

Romo-Nava, Francisco; Blom, Thomas J; Cuellar-Barboza, Alfredo B; Winham, Stacey J; Colby, Colin L; Nunez, Nicolas A; Biernacka, Joanna M; Frye, Mark A; McElroy, Susan L (2020. ) Evening chronotype as a discrete clinical subphenotype in bipolar disorder.Journal of affective disorders, , 266 ,556-562 More Information

McElroy, Susan L; Guerdjikova, Anna I; Romo-Nava, Francisco (2021. ) Diagnosing and treating major depressive episodes that lie along the mood disorders spectrum: focus on depression with mixed features.CNS spectrums, , 26 (2 ) ,133-139 More Information

Cuellar-Barboza, Alfredo B; Cabello-Arreola, Alejandra; Winham, Stacey J; Colby, Colin; Romo-Nava, Francisco; Nunez, Nicolas A; Morgan, Robert J; Gupta, Ruchi; Bublitz, Joshua T; Prieto, Miguel L; De Filippis, Elena A; Lopez-Jimenez, Francisco; McElroy, Susan L; Biernacka, Joanna M; Frye, Mark A; Veldic, Marin (2021. ) Body mass index and blood pressure in bipolar patients: Target cardiometabolic markers for clinical practice.Journal of affective disorders, , 282 ,637-643 More Information

Cuéllar-Barboza, Alfredo B; McElroy, Susan L; Veldic, Marin; Singh, Balwinder; Kung, Simon; Romo-Nava, Francisco; Nunez, Nicolas A; Cabello-Arreola, Alejandra; Coombes, Brandon J; Prieto, Miguel; Betcher, Hannah K; Moore, Katherine M; Winham, Stacey J; Biernacka, Joanna M; Frye, Mark A (2020. ) Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment selection.International journal of bipolar disorders, , 8 (1 ) ,23 More Information

Romo-Nava, Francisco; Blom, Thomas; Cuellar-Barboza, Alfredo B; Awosika, Oluwole O; Martens, Brian E; Mori, Nicole N; Colby, Colin L; Prieto, Miguel L; Veldic, Marin; Singh, Balwinder; Gardea-Resendez, Manuel; Nunez, Nicolas A; Ozerdem, Aysegul; Biernacka, Joanna M; Frye, Mark A; McElroy, Susan L (2021. ) Revisiting the bipolar disorder with migraine phenotype: Clinical features and comorbidity.Journal of affective disorders, , 295 ,156-162 More Information

Guerdjikova, Anna I; Romo-Nava, Francisco; Blom, Thomas J; Mori, Nicole; McElroy, Susan L (2021. ) Study protocol and rationale for a randomized, placebo-controlled trial of solriamfetol to treat binge eating disorder.Contemporary clinical trials, , 110 ,106587 More Information

Singh, Balwinder; Romo-Nava, Francisco; Cuellar-Barboza, Alfredo B (2021. ) Editorial: Neurobiological Underpinnings of Bipolar Disorder and Its Treatment.Frontiers in psychiatry, , 12 ,726362 More Information

Romo-Nava, Francisco; Buijs, Ruud M; McElroy, Susan L (2021. ) The use of melatonin to mitigate the adverse metabolic side effects of antipsychotics.Handbook of clinical neurology, , 179 ,371-382 More Information